Hints and tips:
...From our perspective the strategic rationale of the deal would be limited: GILD’s is currently a similarly sized pharma business to AZN (2020E $25bn on our US colleague’s estimates vs. $26bn on ours for...
...Although the vast majority of physicians received far smaller sums – often limited to a small gift or a sandwich lunch of a few dollars – some studies have suggested even such very modest support can affect...
International Edition